• About
  • Subscribe
  • Advertise
  • Contact
Thursday, January 22, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Breaking News

Telehealth Medicare expansion to cover allied health

by rhiannon bowman
March 24, 2020
in Breaking News, Local, News
Reading Time: 4 mins read
A A
Health Minister Greg Hunt says Australia cannot risk a reduction in the standard of medical care.

Health Minister Greg Hunt says Australia cannot risk a reduction in the standard of medical care.

Share on FacebookShare on Twitter

Telehealth Medicare items will be expanded to encompass allied health professionals, such as optometrists, by Monday as the Federal Government works to maintain access to healthcare amid the COVID-19 crisis.

Federal Health Minister Mr Greg Hunt made the announcement yesterday alongside Professor Michael Kidd, the principal medical advisor to the Department of Health and Professor of Primary Care Reform at the Australian National University.

It will be the fourth stage in a rapid expansion of telehealth services that can be delivered under Medicare during the pandemic. Currently, there are 20 new items with mandatory bulk-billing that have been added for specialists, including ophthalmologists, consultant physicians and psychiatrists.

“We are looking by Monday of next week at having a whole of population telehealth capacity; that means for mental health, allied health and general practice,” Hunts said, while also cautioning against inappropriate item use.

“It is important that this is done carefully to ensure these new items do not have unintended adverse consequences for patients or the health system, while allowing general practitioners and medical specialists to continue to work during the pandemic, using phone and video where clinically appropriate.”

Hunt said he recognised telehealth was not appropriate for the management of all healthcare problems and, in many cases, face-to-face consultations would still be necessary.

“It is imperative Australians continue to receive the high-quality medical care and advice they expect and deserve from their health care providers. We cannot risk a reduction in the standard of medical care provided to the people of Australia,” he said.

“We emphasise the importance of using telehealth item numbers responsibly, appropriately and for the right reasons during this pandemic.”

For details on when telehealth items can be used, Hunt urged health professionals to consult www.mbsonline.gov.au.

“This is new territory for many healthcare providers, who want to meet the challenges of providing health care during this medical crisis.”

In a live televised announcement in Canberra, Kidd added: “The experience of other epidemics around the world shows us that if the primary care system collapses, we are at risk of more loss of life for regular conditions that could have been prevented perhaps more than from the infectious agent itself.”

The announcement builds on the Australian Government’s initial Medicare response to COVID-19, which included 10 new videoconference and 10 telephone items for specialists, consultant physicians and psychiatrists to provide services to vulnerable people within the community or in suspect cases in self-isolation due to COVID-19.

These were later upgraded to enable provision of services via telehealth where the health professional is in isolation or quarantine due to the virus.

RANZCO has confirmed to its members that bulk-billed telephone consultation services can be provided by specialists, which includes ophthalmologists, for certain vulnerable or isolated patients who meet a strict criteria.

Lock-down for NZ optometrists

Meanwhile, the New Zealand Association of Optometrists (NZAO) Council advised its members on Tuesday that all non-essential businesses, which comprises optometry, must shut down at noon on 25 March for at least four weeks.

Their recommendation followed New Zealand Prime Minister Jacinda Ardern’s directive that the nation’s COVID-19 alert was escalating into lock-down of all non-essential services.

“Our understanding is that optometry is not currently listed as an essential service, which means that in most instances NZAO recommends that optometry practices should make plans to close by noon on 25 March,” an NZAO statement said.

The association acknowledged that some members are currently in discussion with their local District Health Board eye clinics and medical centres to continue to provide community eye health services.

“If members wish to provide eye health services after 12 noon on 25 March, then you must have appropriate personal protective equipment for yourself and staff, and appropriate infection control protocols for your patients,” NZAO advised.

On Monday, Optometry Australia stated that it expected there to be further announcements that may impact optometry in coming days and weeks

“And [we] hope to have positive news in the near future about telehealth and Medicare opportunities for optometry,” it stated.

“We believe we have a duty to support [our members] to protect the health of [their] colleagues, patients and communities. To this end we are seeking to advise governments on how time-sensitive and emergency optometric care can continue to be provided, should more extensive service shut-downs be mandated by governments in order to limit the further spread of COVID-19.”

Tags: Greg HuntMBSMedicareMichael Kiddophthalmologistoptometristprimary caretelehealth

Related Posts

The investigational device combines ultra-widefield OCT with AI to enable rapid, non-invasive imaging of the retinas of premature infants. Image: Nenov Brothers/stock.adobe.com.

Handheld ultra-widefield OCT and AI system advances ROP diagnosis

by Staff Writer
January 22, 2026

Researchers at the OHSU Casey Eye Institute have developed the world’s first handheld ultra-widefield optical coherence tomography (OCT) system for...

A common Parkinson’s disease medication may reduce the risk of AMD progression. Image: Siam/stock.adobe.com

Parkinson’s drug may lower risk of AMD progression, study finds

by Staff Writer
January 22, 2026

A recent study suggests that levodopa, a common Parkinson’s disease medication, may reduce the risk of progression from early-stage age-related...

The implant combines lab-grown human embryonic stem cell-derived RPE cells with an ultrathin synthetic parylene scaffold. Image: catalin/stock.adobe.com

Stem-cell retinal implant shows promise in dry AMD

by Staff Writer
January 21, 2026

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited